文献速递泌尿系结石

全州质量改进协作减少输尿管镜术后阿片类药物使用而不影响患者结局

Reducing Opioid Utilization After Ureteroscopy Without Compromising Patient Outcomes in a Statewide Quality Improvement Collaborative.
PubMed 文献 · Urology · 2026-01-13

密歇根泌尿外科质量改进协作(MUSIC)的ROCKS项目评估了减少输尿管镜术后阿片类药物处方的措施对患者报告结局的影响。结果显示,阿片类药物处方率从2016年的83%降至2023年的13%,且出院时未用阿片类药物、后续需要补救阿片类药物的患者与出院时即用阿片类药物的患者相比,患者报告结局无显著差异。术后支架置入是疼痛的独立预测因素。

要点

  • 输尿管镜术后阿片类药物处方率从2016年83%降至2023年13%。
  • 出院时无阿片类药物、后续需补救阿片类药物的患者与出院即用阿片类药物的患者报告结局无显著差异。
  • 术后支架置入和术前支架使用是疼痛强度和干扰的预测因素。

核心结论

  • 减少输尿管镜术后阿片类药物处方未导致患者报告结局恶化,支持多模式镇痛方案。
  • 术后支架使用是疼痛的关键可干预预测因素。

研究设计与样本

  • 基于MUSIC ROCKS倡议的多中心质量改进研究,纳入405例未使用过阿片类药物的输尿管镜手术患者,比较阿片类药物使用与非使用者的PROMIS疼痛评分。

主要发现

  • 阿片类药物处方率从2016年83%下降至2023年13%。
  • 405例阿片类药物初治患者中,23%在术后7-10天内报告使用阿片类药物。
  • 术后7-10天使用阿片类药物的患者疼痛强度和干扰评分更差。
  • 出院时处方阿片类药物者与需要补救阿片类药物者之间的患者报告结局无统计学显著差异。
  • 疼痛强度和干扰的多变量预测因素包括术后7-10天阿片类药物使用、术后支架置入和术前支架使用。

临床怎么用

  • 输尿管镜术后可安全减少阿片类药物处方,采用多模式镇痛方案。
  • 对于出院时未用阿片类药物但后续需要补救的患者,不必常规预先处方阿片类药物。
  • 关注术后支架置入对疼痛的影响,考虑可干预措施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the impact on patient-reported outcomes of the efforts by the Michigan Urological Surgery Improvement Collaborative (MUSIC) Reducing Operative Complications from Kidney Stones (ROCKS) initiative to reduce postoperative opioid use after ureteroscopy. METHODS: We evaluated MUSIC ROCKS patients with complete prescription and PRO data. PROMIS pain intensity and interference scores were compared between opioid and non-opioid users using multivariable regression models. A sub-analysis compared opioid users discharged with multimodal therapy and then required rescue opioids versus those given opioid at discharge. RESULTS: Opioid prescription rates after ureteroscopy declined from 83% in 2016 to 13% in 2023. Of the 405 opioid-naïve ureteroscopy cases; 23% reported opioid use within 7-10 days post-op. At 7-10 days after surgery, patients taking opioids had worse pain intensity and pain interference than those who had not. However, there were no statistically significant differences in PROs between those prescribed opioid at discharge versus those who required rescue opioid. Multivariable predictors of both pain intensity and interference included postoperative opioid use at 7-10 days, postoperative stent placement and preoperative stent use. CONCLUSION: Opioid use after ureteroscopy has declined sharply in Michigan. We did not see evidence that PROs differed between patients discharged opioid-free who later required rescue opioids and those discharged with opioids, supporting the use of multimodal regimens. Postoperative stent use, however, was a key predictor of pain, highlighting its modifiable impact on outcomes.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Sui W, Krishna S, Becker R, et al. Reducing Opioid Utilization After Ureteroscopy Without Compromising Patient Outcomes in a Statewide Quality Improvement Collaborative. Urology. 2026. PMID: 41539397. doi:10.1016/j.urology.2025.12.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。